These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2032955)

  • 1. A new series of carbapenem antibiotics with 5'-substituted pyrrolidinylthio group at C-2 position.
    Sunagawa M; Matsumura H; Inoue T; Fukasawa M; Kato M
    J Antibiot (Tokyo); 1991 Apr; 44(4):459-62. PubMed ID: 2032955
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and antibacterial activities of 4-pyrrolidinylthio carbapenems: containing heteroaromatics as a side chain.
    Cho HW; Oh CH; Lee JS; Lee SC; Choi JH; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):495-503. PubMed ID: 14639741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel carbapenem antibiotic, SM-7338 structure-activity relationships.
    Sunagawa M; Matsumura H; Inoue T; Fukasawa M; Kato M
    J Antibiot (Tokyo); 1990 May; 43(5):519-32. PubMed ID: 2358404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New penem compounds with 5'-substituted pyrrolidinylthio group as a C-2 side chain; comparison of their biological properties with those of carbapenem compounds.
    Sunagawa M; Matsumura H; Inoue T; Fukasawa M
    J Antibiot (Tokyo); 1992 Apr; 45(4):500-4. PubMed ID: 1592682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel C-2 substituted carbapenem derivatives. Part I. Synthesis and biological activity of non-aromatic heterocyclic derivatives.
    Burton G; Clear NJ; Eglington AJ; Guest AW; Hunt E; Naylor A; Pearson MJ; Takle AK
    J Antibiot (Tokyo); 1996 Dec; 49(12):1258-65. PubMed ID: 9031672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistry.
    Burton G; Clarke GJ; Douglas JD; Eglington AJ; Frydrych CH; Hinks JD; Hird NW; Hunt E; Moss SF; Naylor A; Nicholson NH; Pearson MJ
    J Antibiot (Tokyo); 1996 Dec; 49(12):1266-74. PubMed ID: 9031673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial activity of 1 beta-methyl-2-(5-substituted imidazolino pyrrolidin-3-ylthio)carbapenem derivatives.
    Oh CH; Lee CS; Lee JS; Cho JH
    Arch Pharm (Weinheim); 2003 Nov; 336(11):504-9. PubMed ID: 14639742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems.
    Imamura H; Ohtake N; Shimizu A; Sato H; Sugimoto Y; Sakuraba S; Nagano R; Nakano M; Abe S; Suzuki-Sato C; Nishimura I; Kojima H; Tsuchiya Y; Yamada K; Hashizume T; Morishima H
    Bioorg Med Chem; 2000 Aug; 8(8):1969-82. PubMed ID: 11003142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity.
    Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Shitara E; Iwamatsu K; Atsumi K
    Bioorg Med Chem Lett; 2009 Jan; 19(2):447-50. PubMed ID: 19056265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
    Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
    Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel C-2 substituted carbapenem derivatives. Part IV. Synthesis and biological activity of five membered heteroaromatic derivatives.
    Branch CL; Burton G; Clarke GJ; Coulton S; Douglas JD; Eglington AJ; Guest AW; Hinks JD; Hird NW; Holland RK; Hunt E; Knott SJ; Moss SF; Naylor A; Pearson MJ; Takle AK
    J Antibiot (Tokyo); 1998 Feb; 51(2):210-20. PubMed ID: 9544943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of 2-(5-substituted pyrrolidin-4-ylthio)-1 beta-carbapenems.
    Lee HW; Kim EN; Kang TW; Ahn SK; Choi NH; Kim JW; Hong CI
    J Antibiot (Tokyo); 1997 Dec; 50(12):1078-82. PubMed ID: 9510920
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent updates of carbapenem antibiotics.
    El-Gamal MI; Brahim I; Hisham N; Aladdin R; Mohammed H; Bahaaeldin A
    Eur J Med Chem; 2017 May; 131():185-195. PubMed ID: 28324783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems. Part 2: J-111,225, J-114,870, J-114,871 and related compounds.
    Imamura H; Ohtake N; Shimizu A; Sato H; Sugimoto Y; Sakuraba S; Kiyonaga H; Suzuki-Sato C; Nakano M; Nagano R; Yamada K; Hashizume T; Morishima H
    Bioorg Med Chem Lett; 2000 Jan; 10(2):115-8. PubMed ID: 10673092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis and anti-MRSA activity of amidinium-substituted 2-dibenzofuranylcarbapenems.
    Laub JB; Greenlee ML; DiNinno F; Huber JL; Sundelof JG
    Bioorg Med Chem Lett; 1999 Oct; 9(20):2973-6. PubMed ID: 10571158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of novel parenteral carbapenems, CS-023 (R-115685) and related compounds containing an amidine moiety.
    Kawamoto I; Shimoji Y; Kanno O; Kojima K; Ishikawa K; Matsuyama E; Ashida Y; Shibayama T; Fukuoka T; Ohya S
    J Antibiot (Tokyo); 2003 Jun; 56(6):565-79. PubMed ID: 12931867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and SAR of novel carbapenem antibiotics with high stability to Xanthomonas maltophilia oxyiminocephalosporinase type II.
    Hakimelahi GH; Moosavi-Movahedi AA; Tsay SC; Tsai FY; Wright JD; Dudev T; Hakimelahi S; Lim C
    J Med Chem; 2000 Oct; 43(20):3632-40. PubMed ID: 11020277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of 1beta-methylcarbapenems with quaternary ammonium side chains.
    Ishikawa K; Kojima K; Miyauchi M; Endo R; Yasuda H; Kawamoto I
    J Antibiot (Tokyo); 1998 Aug; 51(8):757-70. PubMed ID: 9766468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel 1beta-methylcarbapenem, J-111,225: effects of the C-3 and C-5 stereochemistry of the pyrrolidinylthio side chain on antibacterial activities.
    Imamura H; Shimizu A; Sato H; Sugimoto Y; Sakuraba S; Nagano R; Yamada K; Hashizume T; Morishima H
    J Antibiot (Tokyo); 2000 Mar; 53(3):314-6. PubMed ID: 10819306
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure-activity relationships of penem antibiotics: crystallographic structures and implications for their antimicrobial activities.
    Tanaka R; Oyama Y; Imajo S; Matsuki S; Ishiguro M
    Bioorg Med Chem; 1997 Jul; 5(7):1389-99. PubMed ID: 9377099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.